EPIC Test Compendium Alpha
Welcome to the new Northwell Health Labs Test Directory, please call our Client Services Department at 1-800-472-5757 with any typos, corrections or issues.

Heparin Induced Platelet Antibody

Test Catalog Information

Test Catalog Synonyms

PF4
HIT

EPIC Synonyms HIT
HIPA
PF4
Cerner Primary MnemonicHeparin Induced Platelet AB
EPIC Display NameHeparin Induced Platelet Antibody
Allscripts (AEHR) Order Name

Heparin Induced Platelet Antibody

Sunrise Clinical Manager (SCM) Order Name

Heparin Induced Platelet Antibody

EPIC Inpatient Orderable Yes
EPIC Outpatient Orderable Yes
Cerner Results Heparin-PF4 AB Result
Heparin-PF4 AB Interp
Heparin-PF4 AB Result
Clinical Info

Evaluation of possible immune-mediated type II heparin-induced thrombocytopenia (HIT-II) which should be suspected for the following patients: -Patients not previously exposed to heparin, the development of absolute thrombocytopenia or decrease in platelet count of ≥50% from baseline or postoperative peak with the onset of thrombocytopenia beginning approximately 5 to 10 days after initiation of heparin. This may or may not be associated with new or progressive thrombosis in patients treated with heparin. -Patients previously exposed to heparin (especially within the preceding 100 days), in addition to the above findings, the onset of thrombocytopenia could occur within 24 to 48 hours after reexposure to heparin. In patients with prior suspected or documented heparin-induced thrombocytopenia (HIT), with or without thrombosis, assay for presence of human platelet factor 4 (H/PF4) antibody may be useful in assessment of the risk of recurrence of HIT with additional exposure to heparin, however, prospective data are limited.  

Specimen Type

Blood

Container

Blue Top Tube

Collection Instructions

Container/Tube:  Light Blue Citrated tube Specimen:  0.5-1.0 mL platelet poor citrated plasma Transport Temperature:  Refrigerate or Frozen   Collection Instructions: 1. If the light blue top tube is the only tube to be drawn and will be collected using a butterfly set, a “discard” tube (either a plain[non-additive] or light blue) must be partially drawn just to completely fill the collection tubing with blood before collecting the light blue top for testing.  2. Allow blood to fill the tube completely to the line on the tube.  The ratio of blood to anticoagulant is critical in coagulation testing and at least a 90% fill is required. 3. Immediately mix the specimen by gently inverting the tube 4-6 times to completely mix with the anticoagulant.  Failure to perform this can result in a clotted sample, which is unacceptable for testing.       4. If centrifugation of the specimen cannot be performed immediately after collection, whole blood can be kept in the blue top tube at room temperature (18-24° C) for up to 4 hours.  5. If centrifugation is possible, and transport to the lab will not occur within 1 hour, spin down, remove the plasma to a clean plastic transport tube using a plastic transfer pipette, and spin the plasma again. Remove the plasma with a clean plastic transfer pipette to a fresh transport container and freeze this citrated platelet-poor plasma immediately.  A double centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results.   6. Each coagulation assay requested should have its own vial of citrated plasma,1.0mL each.  

Transport Instructions

Refrigerate or Frozen

Specimen Stability

Methodology

Latex Immunoturbidimetric Asssay

Days Performed

Monday through Sunday TAT - 2 hrs

Performing Laboratory

Northwell Health Laboratories

CPT

86022   LOINC Code:  57761-9

PDM

5700180

Desired Epic Build Heparin Induced Platelet Antibody

Cerner Primary Mnemonic: Heparin Induced Platelet AB
PDM 5700180
Informatics - WorkgroupHematology
Synonyms *HIT
HIPA
PF4
Display Name *Heparin Induced Platelet Antibody
Order Entry Specimen Sources *
Order Entry Specimen Types
Blood
Specimen Navigator Specimen Types
Specimen Navigator Specimen Sources
Specimen Navigator Short Name
Ordering info (EPIC SmartText)Evaluation of possible immune-mediated type II heparin-induced thrombocytopenia (HIT-II) which should be suspected for the following patients: -Patients not previously exposed to heparin, the development of absolute thrombocytopenia or decrease in platelet count of ≥50% from baseline or postoperative peak with the onset of thrombocytopenia beginning approximately 5 to 10 days after initiation of heparin. This may or may not be associated with new or progressive thrombosis in patients treated with heparin. -Patients previously exposed to heparin (especially within the preceding 100 days), in addition to the above findings, the onset of thrombocytopenia could occur within 24 to 48 hours after reexposure to heparin. In patients with prior suspected or documented heparin-induced thrombocytopenia (HIT), with or without thrombosis, assay for presence of human platelet factor 4 (H/PF4) antibody may be useful in assessment of the risk of recurrence of HIT with additional exposure to heparin, however, prospective data are limited.  
IP Orderable Yes
OP Orderable Yes
AOEs *

AP AOEs
Special History No
Build Comments
Filter *
Procedure Category Change
Cerner Results

Result DescResult displayResult PDM
HIPA RES Heparin-PF4 AB Result 5700185
HIPA INT Heparin-PF4 AB Interp 5700196
HIPA RES Heparin-PF4 AB Result 5700185A

Actual Epic build

Procedure Id 64666
Pdm 5700180
Order Display Name Heparin Induced Platelet Antibody
Procedure Name HEPARIN-INDUCED PLATELET ANTIBODY
Procedure Master Number LAB766
Short Procedure Name HEPARIN DEPENDENT ANTIBO
Category Code 1.0
Category Code Record Name LAB BLOOD ORDERABLES
Synonyms ANTIBODIES HEPARIN INDUCED PLATELET ANTIBODY HIPA HITA HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODY
Clinically Active Yes
Orderable Yes
Performable Yes
Filter Genomics
Reference Link Url https://labs.northwell.edu/epic/test/64666
Ordering Instructions
Default Specimen Type Blood
Specimen Type Pick List Blood
Specimen Type List
Op Specimen Type List
Specimen Source Pick List Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous
Specimen Source Default - Male Blood, Venous
Specimen Source Default - Female Blood, Venous
Specimen Source List
Op Specimen Source List
Ip Lab Test Components For Report
Op Lab Test Components For Report
Order Questions []
Order Questions Record Name
Inpatient Order Questions []
Inpatient Order Questions Record Name
Order Specific Question Override
Inpatient Question Override
Location Restrict List Ip
Location Restrict List Ip Record Name
Location Restrict List Include Ip
Location Restrict List Op
Location Restrict List Op Record Name
Location Restrict List Includes Op
Edp Amb Order Specific Questions Record Name
Edp Ip Order Specific Questions Record Name
Edp Ip Specimen Source Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary
Edp Op Specimen Source
Edp Ip Specimen Type Blood
Edp Op Specimen Type
Derived Edp Ip Buttons S Blood, Capillary Blood, Venous Blood, Central Line Blood, Arterial
Derived Edp Ip Buttons T Blood
Derived Edp Op Buttons S
Derived Edp Op Buttons T
Ip Orderable 1
Op Orderable 1
EPIC OP AOEs

EPIC IP AOEs

EPIC Components (results)

Component IDComponent NameBase NameCommon NameExternal NameCerner Result PDM
3046000232.0 HEPARIN-PF4 AB EIA HEPPF4ABEIA HEPARIN-PF4 AB EIA 5700185
3048100234.0 HEPARIN-PF4 AB INTERP HEPABINTRP HEP AB INTERP 5700196
3046000232.0 HEPARIN-PF4 AB EIA HEPPF4ABEIA HEPARIN-PF4 AB EIA 5700185A